CV Sciences (CVSI) Other Non-Current Assets (2013 - 2026)

CV Sciences' (CVSI) quarterly Other Non-Current Assets came in at $47000.0 in Q1 2026, down 52.53% year-on-year from $99000.0 in Q1 2025, and little changed quarter-over-quarter from $47000.0 in Q4 2025.

CV Sciences (CVSI) Other Non-Current Assets (2013 - 2026) Analysis & Trends

CV Sciences has disclosed Other Non-Current Assets across 14 years of filings, most recently posting $47000.0 for Q1 2026.

  • Other Non-Current Assets for Q1 2026 came in at $47000.0, down 52.53% year-over-year; the trailing twelve-month figure through Mar 2026 was $47000.0 (down 52.53% YoY), and the FY2025 annual result was $47000.0, changed N/A from the prior year.
  • Other Non-Current Assets came in at $47000.0 for Q1 2026 at CV Sciences, roughly flat from $47000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $626000.0 in Q1 2022 to a low of $47000.0 in Q3 2025.
  • The 5-year median for Other Non-Current Assets is $244000.0 (2024), against an average of $294066.7.
  • Across the five-year window, Other Non-Current Assets grew 24.95% in 2022 and tumbled 69.48% in 2025, its largest moves.
  • CV Sciences' Other Non-Current Assets stood at $505000.0 in 2022, then tumbled by 31.09% to $348000.0 in 2023, then slumped by 55.75% to $154000.0 in 2024, then sank by 69.48% to $47000.0 in 2025, then changed by 0.0% to $47000.0 in 2026.
  • The last three Other Non-Current Assets figures came in at $47000.0 (Q1 2026), $47000.0 (Q4 2025), and $47000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 1.79 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 351.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 233.20 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 3.45 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 73.60 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 295.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 59.36 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn -
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 47.63 Mn
10 CV Sciences - - 1.56 Mn 47,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 47,000.00
Dec 31, 2025 47,000.00
Sep 30, 2025 47,000.00
Jun 30, 2025 72,000.00
Mar 31, 2025 99,000.00
Sep 30, 2024 154,000.00
Jun 30, 2024 202,000.00
Mar 31, 2024 244,000.00
Sep 30, 2023 348,000.00
Jun 30, 2023 401,000.00
Mar 31, 2023 452,000.00
Dec 31, 2022 505,000.00
Sep 30, 2022 557,000.00
Jun 30, 2022 610,000.00
Mar 31, 2022 626,000.00
Dec 31, 2021 678,000.00
Sep 30, 2021 730,000.00
Jun 30, 2021 501,000.00
Mar 31, 2021 501,000.00
Dec 31, 2020 500,000.00